However, the Competition Appeal Tribunal (Tribunal) has imposed reduced fines of £ 27.1 million on the companies involved. Patients rely on paroxetine to relieve symptoms of depression. GlaxoSmithKline plc (GSK)…
However, the Competition Appeal Tribunal (Tribunal) has imposed reduced fines of £ 27.1 million on the companies involved. Patients rely on paroxetine to relieve symptoms of depression. GlaxoSmithKline plc (GSK)…